Parisi Insurance Blog FDA Announces new breast cancer drug

The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones. The drug is called Kadcyla (kad-SY'-luh) chemically combines the established drug Herceptin with a powerful chemotherapy drug. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a double-shot of anti-tumor poison. Overall, patients taking Kadcyla lived about 2.6 years, compared with 2 years for patients taking the other drugs. It is estimated that Kadcyla will cost $9,800 per month, compared to $4,500 per month for regular Herceptin. A full course of Kadcyla, about nine months of medicine, is estimated to cost $94,000.Read more: http://www.foxnews.com/health/2013/02/22/fda-approves-new-targeted-breast-cancer-drug/?intcmp=HPBucket#ixzz2LwJhWclDDo you know if your health insurance plan would cover a drug like Kadcyla? Many people don't know what kind of prescription benefits they are entitled to until they develop a serious medical condition such as breast cancer. That is why it is very important to be on a plan that has solid prescription benefits. You never know when you might need a specialty drug like Kadcyla to save your life. If you are unsure of your prescription benefits, call us today. One of our experienced licensed agents can explain your benefits to you, and if necessary, help you take steps to change your plan to one that offers quality prescription benefits.